Natural product-based therapy for Metastatic cancers: Curcumin, the major component of turmeric, suppresses the expression of Metadherin via up regulation of its target gene, 23/October/2014, 14.25

Therapeutic insight into the treatment of Age-related Cataract: 1,25-dihydroxyvitamin D promotes the surivival of lens epithelial cells via up regulation of its target gene, 23/October/2014, 14.17
October 23, 2014
Anti-metastasis therapy: Angiopoietin-like protein 1 decreases the expression of Lin28B via down regulation of its target gene, 23/October/2014, 14.31
October 23, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

CitationBoominathan, L., Natural product-based therapy for Metastatic cancers: Curcumin, the major component of turmeric, suppresses the expression of Metadherin via up regulation of its target gene, 23/October/2014, 14.25, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests that Curcumin, by increasing the expression of its target gene, it may decrease the expression of Metadherin.  Therefore, pharmacological formulations encompassing “Curcumin or its analogues may be used to treat metastatic cancers.

Amount: $300

Undisclosed information: How Curcumin decreases Metadherin expression.

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.